Cargando…

Functional magnetic resonance imaging, deep learning, and Alzheimer's disease: A systematic review

Alzheimer's disease (AD) is currently diagnosed using a mixture of psychological tests and clinical observations. However, these diagnoses are not perfect, and additional diagnostic tools (e.g., MRI) can help improve our understanding of AD as well as our ability to detect the disease. Accordin...

Descripción completa

Detalles Bibliográficos
Autores principales: Warren, Samuel L., Moustafa, Ahmed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092597/
https://www.ncbi.nlm.nih.gov/pubmed/36257926
http://dx.doi.org/10.1111/jon.13063
_version_ 1785023383833935872
author Warren, Samuel L.
Moustafa, Ahmed A.
author_facet Warren, Samuel L.
Moustafa, Ahmed A.
author_sort Warren, Samuel L.
collection PubMed
description Alzheimer's disease (AD) is currently diagnosed using a mixture of psychological tests and clinical observations. However, these diagnoses are not perfect, and additional diagnostic tools (e.g., MRI) can help improve our understanding of AD as well as our ability to detect the disease. Accordingly, a large amount of research has been invested into innovative diagnostic methods for AD. Functional MRI (fMRI) is a form of neuroimaging technology that has been used to diagnose AD; however, fMRI is incredibly noisy, complex, and thus lacks clinical use. Nonetheless, recent innovations in deep learning technology could enable the simplified and streamlined analysis of fMRI. Deep learning is a form of artificial intelligence that uses computer algorithms based on human neural networks to solve complex problems. For example, in fMRI research, deep learning models can automatically denoise images and classify AD by detecting patterns in participants’ brain scans. In this systematic review, we investigate how fMRI (specifically resting‐state fMRI) and deep learning methods are used to diagnose AD. In turn, we outline the common deep neural network, preprocessing, and classification methods used in the literature. We also discuss the accuracy, strengths, limitations, and future direction of fMRI deep learning methods. In turn, we aim to summarize the current field for new researchers, suggest specific areas for future research, and highlight the potential of fMRI to aid AD diagnoses.
format Online
Article
Text
id pubmed-10092597
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-100925972023-04-13 Functional magnetic resonance imaging, deep learning, and Alzheimer's disease: A systematic review Warren, Samuel L. Moustafa, Ahmed A. J Neuroimaging Review Articles Alzheimer's disease (AD) is currently diagnosed using a mixture of psychological tests and clinical observations. However, these diagnoses are not perfect, and additional diagnostic tools (e.g., MRI) can help improve our understanding of AD as well as our ability to detect the disease. Accordingly, a large amount of research has been invested into innovative diagnostic methods for AD. Functional MRI (fMRI) is a form of neuroimaging technology that has been used to diagnose AD; however, fMRI is incredibly noisy, complex, and thus lacks clinical use. Nonetheless, recent innovations in deep learning technology could enable the simplified and streamlined analysis of fMRI. Deep learning is a form of artificial intelligence that uses computer algorithms based on human neural networks to solve complex problems. For example, in fMRI research, deep learning models can automatically denoise images and classify AD by detecting patterns in participants’ brain scans. In this systematic review, we investigate how fMRI (specifically resting‐state fMRI) and deep learning methods are used to diagnose AD. In turn, we outline the common deep neural network, preprocessing, and classification methods used in the literature. We also discuss the accuracy, strengths, limitations, and future direction of fMRI deep learning methods. In turn, we aim to summarize the current field for new researchers, suggest specific areas for future research, and highlight the potential of fMRI to aid AD diagnoses. John Wiley and Sons Inc. 2022-10-18 2023 /pmc/articles/PMC10092597/ /pubmed/36257926 http://dx.doi.org/10.1111/jon.13063 Text en © 2022 The Authors. Journal of Neuroimaging published by Wiley Periodicals LLC on behalf of American Society of Neuroimaging. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Review Articles
Warren, Samuel L.
Moustafa, Ahmed A.
Functional magnetic resonance imaging, deep learning, and Alzheimer's disease: A systematic review
title Functional magnetic resonance imaging, deep learning, and Alzheimer's disease: A systematic review
title_full Functional magnetic resonance imaging, deep learning, and Alzheimer's disease: A systematic review
title_fullStr Functional magnetic resonance imaging, deep learning, and Alzheimer's disease: A systematic review
title_full_unstemmed Functional magnetic resonance imaging, deep learning, and Alzheimer's disease: A systematic review
title_short Functional magnetic resonance imaging, deep learning, and Alzheimer's disease: A systematic review
title_sort functional magnetic resonance imaging, deep learning, and alzheimer's disease: a systematic review
topic Review Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092597/
https://www.ncbi.nlm.nih.gov/pubmed/36257926
http://dx.doi.org/10.1111/jon.13063
work_keys_str_mv AT warrensamuell functionalmagneticresonanceimagingdeeplearningandalzheimersdiseaseasystematicreview
AT moustafaahmeda functionalmagneticresonanceimagingdeeplearningandalzheimersdiseaseasystematicreview